Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NKGen Biotech, Inc. | 10%+ Owner | Common Stock | 2.44M | $8.02M | $3.29 | Sep 29, 2023 | Direct |
NKGen Biotech, Inc. | 10%+ Owner | Working Capital Warrants | 5.24M | Sep 29, 2023 | Direct | ||
NKGen Biotech, Inc. | 10%+ Owner | Private Placement Warrants | 4.72M | Sep 29, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GFOR | NKGen Biotech, Inc. | Sep 29, 2023 | 3 | $7.87M | 4 | Oct 4, 2023 | 10%+ Owner |
GFOR | Graf Acquisition Corp. IV | Jul 14, 2021 | 1 | $0 | 4 | Jul 14, 2021 | Chief Executive Officer, 10%+ Owner |
GFOR | Graf Acquisition Corp. IV | Jun 2, 2021 | 1 | $0 | 4 | Jun 2, 2021 | Chief Executive Officer, 10%+ Owner |
GFOR | Graf Acquisition Corp. IV | May 20, 2021 | 0 | $0 | 3 | May 20, 2021 | Chief Executive Officer, 10%+ Owner |